Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GlycoAvatars: bead-coated membrane models for studying the cancer-immune cells interactome.

Communications biology·2026
Same author

B cell mechanotransduction via ATAT1 coordinates actin and lysosomal dynamics at the immune synapse.

The Journal of cell biology·2025
Same author

Fusion of Complement Fragment C3d Enhances Germinal Center Responses to HIV-1 Envelope Glycoproteins.

bioRxiv : the preprint server for biology·2025
Same author

High-Resolution Imaging of Intracellular Trafficking of B Cell Receptor Using Specific Hybridization Internalization Probe (SHIP).

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Endolysosomal vesicles at the center of B cell activation.

The Journal of cell biology·2024
Same author

The Small GTPase Rab7 Regulates Antigen Processing in B Cells in a Possible Interplay with Autophagy Machinery.

Cells·2023

Related Experiment Video

Updated: Jun 3, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.7K

Enhanced antibody responses in CD19-Cre mice.

Diogo M Cunha1,2,3, Sara Hernández-Pérez1,2,3,4, Pieta K Mattila5,6,7

  • 1Institute of Biomedicine and MediCity Research Laboratories, University of Turku, Turku, Finland.

Scientific Reports
|January 8, 2025
PubMed
Summary

The CD19-Cre mouse model, used for B cell research, shows altered immune responses. These mice exhibit heightened antibody production and modified B cell activity, impacting their utility in immunological studies.

Keywords:
Antibody responseB cellsBCRCD19Class-switch recombination

More Related Videos

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

1.8K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.9K

Related Experiment Videos

Last Updated: Jun 3, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.7K
Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

1.8K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.9K

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • The CD19-Cre mouse model is essential for B cell-specific genetic studies.
  • This model involves heterozygosity for CD19, a key B cell receptor coreceptor, leading to reduced CD19 expression.
  • The impact of diminished CD19 expression on B cell activation remains incompletely understood.

Purpose of the Study:

  • To investigate the consequences of CD19 deficiency in CD19-Cre mice on B cell function and immune responses.
  • To evaluate the utility of the CD19-Cre model in B cell research.

Main Methods:

  • Immunization of CD19-Cre mice with T-dependent (NP-KLH) and T-independent (NP-Ficoll) antigens.
  • Measurement of basal immunoglobulin M (IgM) levels.
  • In vitro B cell stimulation assays (LPS, IFNγ) to assess proliferation and class-switch recombination.
  • Analysis of B cell antigen receptor (BCR) signaling.

Main Results:

  • CD19-Cre mice demonstrated significantly enhanced antibody responses to both T-dependent and T-independent immunizations.
  • Elevated basal IgM levels were observed in CD19-Cre mice.
  • In vitro studies showed enhanced B cell class-switch recombination but reduced proliferation upon stimulation, with no major changes in BCR signaling.

Conclusions:

  • The CD19-Cre model exhibits altered B cell responses, including heightened antibody production and modified B cell activity.
  • These findings suggest that the reduced CD19 expression in CD19-Cre mice significantly impacts B cell function.
  • Researchers should carefully consider these immunological alterations when utilizing the CD19-Cre mouse model for B cell studies.